NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes.

Author(s): Chavez-Macgregor M, Liu S, De Melo-Gagliato D, Chen H, Do KA, Pusztai L, Fraser Symmans W, Nair L, Hortobagyi GN, Mills GB, Meric-Bernstam F, Gonzalez-Angulo AM

Publication: Cancer Epidemiol Biomarkers Prev, 2014, Vol. 23, Page 316-23

PubMed ID: 24296856 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of patient ethnicity on the protein and transcript expression profiles in fine needle aspiration (FNA) breast tumor specimens.

Conclusion of Paper

On average, Hispanic patients had more advanced breast cancer than patients of other races, but none of the 177 proteins were differentially expressed between races. While an initial analysis identified some differentially expressed transcripts in hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2, neu)-positive breast cancer specimens between racial groups, none were confirmed using a second cohort.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of patient ethnicity on the protein and transcript expression profiles by microarray in FNA breast tumor specimens. For microarray analysis, RNA was isolated from 376 FNA specimens and stored frozen at -80 degrees C until analysis using the affymetrix U133A gene chip. Reverse phase protein arrays were conducted to evaluate the levels of 177 proteins using 255 frozen (-80 degrees C) FNA specimens.

    Summary of Findings:

    None of the 177 proteins was differentially expressed between races, but on average, Hispanic patients had more advanced breast cancer than patients of other races (p<0.0001). Using an initial cohort of 62 HER-2 positive tumors, 2 and 384 probes were significantly affected by race in HR-positive and HER-2 positive specimens, respectively, but these results were not duplicated using a second cohort of 59 specimens.

    Biospecimens
    Preservative Types
    • Frozen
    • None (Fresh)
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    RNA DNA microarray
    Protein Reverse phase protein microarray
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Patient race White
    Hispanic
    Black
    Other

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...